Evotec
Elio Llane is currently a Global Tax and Transfer Pricing Working Student at Evotec since January 2024, responsible for the preparation, reconciliation, and submission of VAT reports and EC Sales lists in Elster. Prior to this role, Elio worked at BASF as an Indirect Tax Working Student from January 2023 to January 2024, where responsibilities included the timely submission of VAT returns, advance VAT returns, recapitulative statements, Intrastat returns, and tax compliance management. Elio's accounting experience also includes working as an Accountant at E&V Llane shpk from January 2020 to August 2022, focusing on preparing accounting statements, financial reports, payrolls, and creating advanced Excel documents and presentations. Elio is pursuing a Master’s degree in Management & Sustainable Accounting and Finance at Leuphana University of Lüneburg, expected to graduate in July 2024, and holds a Bachelor’s degree in Finance from the University of Tirana.
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.